Delta 9 Cannabis (VRNDF) Stock Price, News & Analysis

Company Overview

Delta 9 Cannabis Inc. (OTCMKTS: VRNDF) is a Canadian cannabis company engaged in the cultivation, processing and retail of cannabis products. Headquartered in Winnipeg, Manitoba, the company operates a Health Canada–licensed cultivation and processing facility in Flin Flon. Delta 9’s integrated model covers the entire value chain, from plant propagation and flowering to extraction and packaging, enabling the company to produce a range of cannabis offerings under its own brands as well as for strategic partners.

The company’s product portfolio includes dried flower, pre-rolled joints, cannabis oils and softgel capsules, with plans to expand into edibles and beverages pending regulatory approval. Delta 9 markets its products through a network of company-owned retail stores across Manitoba, supplemented by e-commerce capabilities for provincial home delivery. In addition to its core market in Manitoba, the company has pursued strategic acquisitions and partnerships to broaden its retail footprint in other Canadian provinces.

Founded in 2018, Delta 9 Cannabis has grown from a single-store operator into one of Manitoba’s leading cannabis retailers and licensed producers. The firm completed its initial public offering in 2020 on the Canadian Securities Exchange, later securing an over-the-counter listing under the symbol VRNDF for U.S. investors. Led by CEO Jim Caceres, the management team includes executives with extensive experience in regulated consumer products, retail operations and biomedical sciences. Delta 9 continues to invest in capacity expansions and product innovation to address evolving market demand in Canada’s legal cannabis sector.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 76,416 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:VRNDF
• CIK: N/A
• Web: www.delta9.ca
• Phone: 855-245-1259
• Fax: N/A
• Employees: 148
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A